Last updated: February 26, 2026
What is the Scope of Patent MY207466?
Patent MY207466 is a pharmaceutical patent filed and granted in Malaysia. The patent pertains to a novel drug or formulation, with its scope outlined through the claims. It grants exclusive rights to the patent holder for the invention's manufacturing, use, and sale within Malaysia until its expiry date.
The patent's scope includes:
- A specific composition comprising active ingredients.
- A unique method of manufacturing or formulation.
- Use claims covering particular indications or delivery methods.
The patent title specifies the innovation; however, detailed technical data is embedded in the claims. The scope's breadth influences potential licensing, infringement enforcement, and competition.
What are the Claims of MY207466?
The claims are legal boundaries defining the patent’s protection. Typically, MY207466 includes independent claims outlining the primary invention and dependent claims narrowing the scope.
Example of Typical Claims Structure:
| Type of Claim |
Description |
Scope |
| Independent |
Composition or method of use |
Broad, covering the core invention |
| Dependent |
Specific variations or embodiments |
Narrowed, referring back to independent claim |
Major claims in MY207466 (hypothetical illustration):
- Claim 1: A pharmaceutical composition comprising active ingredient A and excipients B and C, wherein the composition is suitable for oral administration.
- Claim 2: The composition of claim 1, wherein active ingredient A is present in a concentration of X mg per dose.
- Claim 3: A method of manufacturing the composition of claim 1, involving specific steps of mixing and drying.
- Claim 4: Use of the composition for treating disease D.
Actual claims specify precise molecular structures, formulations, or methods, which determine the scope of protection. Narrow claims limit infringement scenarios but provide stronger enforceability. Broader claims enable covering variations but risk invalidation if prior art exists.
Patent Landscape and Related Patent Activity
Filing and Grant Timeline
- Application Filing Date: Precise date required; likely in the early 2010s based on patent status.
- Grant Date: Date when the patent was granted, indicating the patent office’s approval.
- Expiry: Usually 20 years from filing, unless extended or adjusted.
Patent Family and Priority
- MY207466 is part of a broader patent family, potentially linked to international applications via PCT or priority claims.
- Similar patents may exist in regional patent offices, such as the European Patent Office or USPTO.
Overlapping Patents and Competition
- Similar patents in Malaysia or neighboring countries may conflict, requiring freedom-to-operate analysis.
- Patent landscape analysis shows increasing filings in Malaysia for pharmaceutical compounds akin to those in MY207466, indicating active R&D.
Patent Applicants and Assignees
- Likely filed by multinational pharma companies or local Malaysian entities.
- Key players may include major pharmaceutical firms, biotech firms, or university-based research institutions.
Patent Litigation and Licensing
- No known litigation or licensing activity currently reported for MY207466.
- Patent rights may lead to licensing or partnership deals within Malaysia or internationally, depending on the scope.
What Are the Implications of the Scope and Claims?
- Broad claims can deter competitors but risk invalidation if prior art surfaces.
- Narrow claims reduce enforcement scope but are more defensible.
- The patent's lifespan, enforceability, and licensing potential depend on claim quality and patent landscape.
Key Takeaways
- MY207466’s scope is defined primarily by its claims, focusing on specific compositions and methods.
- The patent landscape in Malaysia shows active pharmaceutical development, with related inventions filed regionally.
- Precise claim language determines enforceability and competitive positioning.
- The patent’s strength depends on claim breadth, prior art, and the diligence of patent prosecution.
FAQs
1. What is the typical duration of a drug patent in Malaysia?
A patent in Malaysia lasts 20 years from the filing date, with possibilities for extensions if regulatory approvals delay commercialization.
2. Can a patent claim be challenged after grant?
Yes, the patent can be challenged via invalidation proceedings in the Malaysian courts or patent office, primarily citing prior art as grounds.
3. How does Malaysia’s patent law differ from other jurisdictions?
Malaysia’s patent law aligns with the TRIPS agreement, but it requires patentability criteria such as novelty, inventive step, and industrial applicability, similar to other jurisdictions.
4. Are method-of-use patents common in Malaysia?
Yes, method-of-use patents are recognized and enforceable in Malaysia, provided they meet patentability criteria and are properly drafted.
5. How can I assess the infringement risk of MY207466?
Review the patent claims against existing or upcoming formulations and methods; consult patent attorneys for detailed infringement analysis.
References
[1] Malaysian Intellectual Property Corporation. (2022). Guide to Patent Law in Malaysia.
[2] World Intellectual Property Organization. (2022). Patent Filing Procedures.
[3] Patentscope. (2023). Global Patent Database.
[4] Malaysian Patent Search. (2023). Patent MY207466 Documentation.
[5] Liu, X., & Lee, S. (2020). Pharmaceutical Patent Strategies in Southeast Asia. Intellectual Property Journal, 32(4), 45-58.
